Metabolic Disorders
GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Metabolic Disorders market. Reports cover market growth forecasts, trends and research, and more.
Browse our full list of Metabolic Disorders market reports here.
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
- The Price Conversion is only for the Indicative purpose.
- USD — US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
-
Sector Analysis
EpiCast Report: Growth Hormone Deficiency – Epidemiology Forecast to 2026 EpiCast Report: Growth Hormone Deficiency – Epidemiology Forecast to 2026
$3,995 | June 2017 GHD is an endocrine disorder characterized by the insufficient production of GH by the pituitary gland. GHD is more commonly seen in children, although it can develop during adulthood. GHD can be present from birth (congenital), or it can be secondary due to brain trauma (acquired). Generally, a child with GHD is born with normal size at birth, but has delayed rates of bone development and bone lengthening later on. Patients who acquire GHD later in life present with more...
-
Product Insights
Diabetes Insipidus Global Clinical Trials Review, H2, 2017 Diabetes Insipidus Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetes Insipidus Global Clinical Trials Review, H2, 2017" provides an overview of Diabetes Insipidus clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetes Insipidus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Complications Global Clinical Trials Review, H2, 2017 Diabetic Complications Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Complications Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Complications clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Complications. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2017 Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Foot Infection (DFI) clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Infection (DFI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Diabetic Ketoacidosis Global Clinical Trials Review, H2, 2017 Diabetic Ketoacidosis Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Ketoacidosis Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Ketoacidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Ketoacidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Nephropathy Global Clinical Trials Review, H2, 2017 Diabetic Nephropathy Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Nephropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H2, 2017 Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Neuropathic Foot Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Neuropathic Foot Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Diabetic Neuropathy Global Clinical Trials Review, H2, 2017 Diabetic Neuropathy Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Neuropathy Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Neuropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017 Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Peripheral Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Peripheral Neuropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Diabetic Retinopathy Global Clinical Trials Review, H2, 2017 Diabetic Retinopathy Global Clinical Trials Review, H2, 2017
$2,500 | July 2017 GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Retinopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Retinopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.